Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer

Often, patients fail to respond to immune checkpoint inhibitor (ICI) treatment despite favourable biomarker status. Numerous chemotherapeutic agents have been shown to promote tumour immunogenicity when used in conjunction with ICIs; however, little is known about whether such combination therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Goggi, Julian L., Khanapur, Shivashankar, Hartimath, Siddesh V., Ramasamy, Boominathan, Cheng, Peter, Chin, Hui-Xian, Tang, Jun-Rong, Hwang, You-Yi, Robins, Edward G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598730/
https://www.ncbi.nlm.nih.gov/pubmed/36289605
http://dx.doi.org/10.3390/biomedicines10102343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598730/
https://www.ncbi.nlm.nih.gov/pubmed/36289605
http://dx.doi.org/10.3390/biomedicines10102343

Ejemplares similares